Danish Bladder Cancer Patients Show Similar Outcomes in Clinical Practice and Clinical Trials
Two studies evaluating all Danish patients with bladder cancer treated with first-line chemotherapy and all-line pembrolizumab, respectively, have found similar outcomes and overall survival rates between patients treated in clinical practice and those from clinical trials.
Relateret indhold
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen